Trust Company of the Ozarks’s Gilead Sciences GILD Stock Holding History

Trust Company of the Ozarks’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.07M	Buy	21,075 +169	+0.8%	+$18.8K	0.71%	24
2015 Q2	$2.45M	Buy	20,906 +745	+4%	+$81.4K	0.68%	17
2015 Q1	$1.98M	Sell	20,161 -875	-4%	-$88.8K	0.52%	27
2014 Q4	$1.98M	Sell	21,036 -1,090	-5%	-$113K	0.55%	27
2014 Q3	$2.36M	Sell	22,126 -704	-3%	-$68.9K	0.66%	18
2014 Q2	$1.89M	Buy	22,830 +100	+0.4%	+$7.78K	0.51%	28
2014 Q1	$1.61M	Sell	22,730 -2,100	-8%	-$165K	0.45%	36
2013 Q4	$1.86M	Sell	24,830 -1,700	-6%	-$118K	0.53%	25
2013 Q3	$1.67M	Hold	26,530	–	–	0.53%	28
2013 Q2	$1.36M	Buy	+26,530	New	+$1.38M	0.45%	42

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Trust Company of the Ozarks's GILD Position: Q3 2015 in Review

Trust Company of the Ozarks increased its Gilead Sciences (GILD) stake by 0.81% in Q3 2015, buying an estimated $18.8K and bringing the position to 21,075 shares worth $2.07M. The position accounts for 0.71% of the portfolio, ranked #24.

Trust Company of the Ozarks first reported a position in GILD in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.45M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Trust Company of the Ozarks held 21,075 shares of Gilead Sciences worth $2.07M as of Q3 2015.
Trust Company of the Ozarks bought 169 Gilead Sciences shares in Q3 2015, an estimated $18.8K.
Gilead Sciences made up 0.71% of Trust Company of the Ozarks's portfolio in Q3 2015, its #24 holding.
Trust Company of the Ozarks first reported a position in Gilead Sciences in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's Gilead Sciences position peaked at $2.45M in Q2 2015.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.